BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prayugo FB, Kao TJ, Anuraga G, Ta HDK, Chuang JY, Lin LC, Wu YF, Wang CY, Lee KH. Expression Profiles and Prognostic Value of FABPs in Colorectal Adenocarcinomas. Biomedicines 2021;9:1460. [PMID: 34680577 DOI: 10.3390/biomedicines9101460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hoxha M, Zappacosta B. A review on the role of fatty acids in colorectal cancer progression. Front Pharmacol 2022;13:1032806. [PMID: 36578540 DOI: 10.3389/fphar.2022.1032806] [Reference Citation Analysis]
2 Misbah M, Kumar M, Lee K, Shen S, Ergün S. Identification of Novel miRNAs, Targeting Genes, Signaling Pathway, and the Small Molecule for Overcoming Oxaliplatin Resistance of Metastatic Colorectal Cancer. BioMed Research International 2022;2022:1-20. [DOI: 10.1155/2022/3825760] [Reference Citation Analysis]
3 Hou L, Zhou H, Wang Y, Liu J, Zhang D, Li Y, Xue X, Xu Z. Identification of FABP7 as a Potential Biomarker for Predicting Prognosis and Antiangiogenic Drug Efficacy of Glioma. Disease Markers 2022;2022:1-16. [DOI: 10.1155/2022/2091791] [Reference Citation Analysis]